Patent · US Active

Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein

US8541202B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

Alexander Knuth · Frankfurt am Main, DE
Elke Jager · Frankfurt am Main, DE
Yao-Tseng Chen · New York, US
Matthew Scanlan · Princeton Junction, US
Ali Gure · New York, US
Gerd Ritter · New York, US
Lloyd J. Old · New York, US
Jan Wouter Drijfhout · Leiden, NL

Key dates

Filing date	Feb 24, 2012
Grant date	Sep 24, 2013
Priority date	—
Expiry date	Feb 24, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S435/81
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to peptides which bind to MHC Class I and to MHC Class II molecules. These peptides are useful in different therapeutic and diagnostic contexts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.